Syngene International posted 10.81% increase in net profit at Rs 82 crore

2018-01-23 16:42:28

Biocon\'s contract research arm Syngene International reported 10.81 per cent increase in its net profit. Its profit stood at Rs 82 crore for the third quarter ended December 2017.The company had reported a profit of Rs 74 crore for the same period of the previous fiscal.Revenue of the company increased to Rs 399 crore for the third quarter as compared with Rs 347 crore in the same period of the p

Read more

Celgene Corporation spends $9 million to acquire Juno Therapeutics

2018-01-23 16:21:19

Juno is a pioneer in the development of CAR (chimeric antigen receptor) T and TCR (T cell receptor) therapeutics for cancer indications.By Team ABLENASDAQ-listed companies Celgene Corporation and Juno Therapeutics, have announced the signing of a definitive merger agreement in which Celgene has agreed to acquire Juno. Under the terms of the merger agreement, Celgene will pay $87 per share in cash,

Read more

Sinobioway Group invests in Canada’s Enerkem to escalate bio-fuel business

2018-01-23 16:20:08

The investment from Sinobioway is expected to accelerate the global expansion of Enerkem by introducing the latter’s waste-to-biofuels technology to the Chinese market.By Team ABLEChinese bio-industrial conglomerate, Sinobioway Group has made an equity investment of C$125m ($100.2m) in Canada-based Enerkem, a manufacturer of waste-to-biofuels and renewable chemicals.The investment from Sinobiowa

Read more

Sanofi acquires Bioverativ for $11.6 billion; strengthens market share in rare disease therapeutics

2018-01-23 16:18:35

With the acquisition of Bioverativ, Sanofi enhances its presence in specialty care and leadership in rare diseases, in line with its 2020 RoadmapBy Team ABLESanofi and Bioverativ Inc., a biopharmaceutical company focused on therapies for hemophilia and other rare blood disorders, have entered into a definitive agreement under which Sanofi will acquire all of the outstanding shares of Bioverativ fo

Read more

Lucknow chosen to host fourth India International Science Festival

2018-01-23 16:11:25

The decision to hold the festival in Lucknow was taken at the first preparatory meeting for the 4th India International Science Festival chaired by Union Minister Dr. Harsh VardhanBy Team ABLEThe fourth edition of the India International Science Festival will be held in Lucknow. The exact dates and other details will be decided later. The decision to hold the festival in Lucknow was taken at the f

Read more

CSIR forges partnership with Japanese Universities and R&D Organizations

2018-01-23 16:09:54

The CSIR delegation to Japan held bilateral meetings with University of Tokyo and RIKEN Brain Science Institute to build R&D cooperation in areas of mutual interest, aimed at translational research.By Team ABLEThe Council of Scientific and Industrial Research (CSIR) has forged synergistic partnership with Japanese Universities and Research & Development (R&D) organizations to leverage

Read more

test\'s bold issue, question issue, color issue

2018-01-23 06:52:58

ththhth krtjjkjkrtjk this\'s my s\'troy

Read more

Panacea Biotec, Serum Institute of India ink two long-term agreements

2018-01-19 10:24:02

Under the collaboration, Serum Institute of India is entitled to manufacture and sell pertussis and Salk-based injectable polio vaccine-based hexavalent vaccine developed and commercialized by Panacea BiotecBy Team ABLEPopular biotechnology company, Panacea Biotec has signed two long term agreements with Serum Institute of India (SII) and SII\'s wholly owned subsidiary, Bilthovan Biologicals B. Un

Read more

Biocon collaborates with Sandoz on next-generation biosimilars

2018-01-19 09:55:45

This new partnership with Sandoz is a significant milestone in Biocon’s journey of developing advanced therapies that have the potential to benefit billions of patients.By Team ABLEAsia\'s premier biopharmaceuticals company Biocon Ltd and Sandoz, a Novartis division and a global leader in biosimilars, have announced a global partnership to develop, manufacture and commercialize multiple biosimil

Read more

BT cotton seeds effective: Monsanto reports to GoI

2018-01-19 09:54:28

US-based biotech major Monsanto\'s India JV firm MMBL has written to the government asserting that its BT technology seeds continues to be effective in controlling pest.By Team ABLEAt New Delhi, terming that industry body NSAI\'s threat to stop sale of BT cotton seeds as ‘irresponsible’, US-based biotech major Monsanto\'s India JV firm MMBL has written to the government asserting that its BT t

Read more